Managed Oncology Service
(for subscribers only)
-

Trends In Utilization Management
May 2012. Evaluates current clinical pathway implementation and expectations for future development. Analyzes health plans' usage of preferred agent lists, formulary tiers, and utilization management and physician reimbursement tactics.
-

Oncology Patient Cost Sharing
April 2012. Patient cost sharing responsibilities, including distribution of fixed copays, coinsurance, and out-of-pocket limits are evaluated for medical and pharmacy areas.
-

Oncology Account Support
March 2012. Provides quality ratings of pharmaceutical company oncology program components, account managers, and medical science liaisons. Includes highlights of best practices and partnership opportunities.
-

Employer Trends in Oncology Management
February 2012. Identifies the key trends in employers’ approaches to the management of oncology treatments. Assesses the use of specialty pharmacies, utilization management techniques, use of preferred agents, and oncology-specific health management initiatives.
-

Case Study: Clinical Pathways for the Management of Oncology
January 2012. Three case studies highlight trends in oncology management, including clinical pathways development for national and regional health plans, Pfizer's Oncology Patient Navigator, and Genentech's case management program for breast cancer.

Ms. Segal holds an MBA from Columbia University and is a cum laude graduate of Barnard College. Since joining HIRC in 2001, she has conducted primary research, analyses and writing for HIRC’s Best Programs & Best People Service, Disease Management Service and Specialty Pharmaceuticals Service. Prior to her work at HIRC, Julia was employed by Merck & Co., Inc for eleven years in a variety of sales and marketing positions, culminating in the position of Director of Market Research at Medco.